All Stories

  1. A recombinant Artemisia vulgaris pollen adjuvanted Art v 1 protein-based vaccine treats allergic rhinitis and bronchial asthma using pre- and co-seasonal ultrashort immunotherapy regimens in sensitized mice

    Article • Frontiers in Immunology, November 2022, Frontiers

    Professor Kaissar Tabynov

  2. Evaluation of a Novel Adjuvanted Vaccine for Ultrashort Regimen Therapy of Artemisia Pollen-Induced Allergic Bronchial Asthma in a Mouse Model

    Article • Frontiers in Immunology, March 2022, Frontiers

    Professor Kaissar Tabynov

  3. A Spike Protein-Based Subunit SARS-CoV-2 Vaccine for Pets: Safety, Immunogenicity, and Protective Efficacy in Juvenile Cats

    Article • Frontiers in Veterinary Science, March 2022, Frontiers

    Professor Kaissar Tabynov

  4. An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission

    Article • npj Vaccines, February 2022, Springer Science + Business Media

    Professor Kaissar Tabynov

  5. Cooperative Research and Infectious Disease Surveillance: A 2021 Epilogue

    Article • Frontiers in Public Health, January 2022, Frontiers

    Professor Kaissar Tabynov

  6. Registered Influenza Viral Vector Based Brucella abortus Vaccine for Cattle in Kazakhstan: Age-Wise Safety and Efficacy Studies

    Article • Frontiers in Cellular and Infection Microbiology, July 2021, Frontiers

    Professor Kaissar Tabynov

  7. Nanobody Nb6 fused with porcine IgG Fc as the delivering tag to inhibit porcine reproductive and respiratory syndrome virus replication in porcine alveolar macrophages

    Article • Veterinary Research, February 2021, Springer Science + Business Media

    Professor Kaissar Tabynov

  8. A new candidate vaccine for human brucellosis based on influenza viral vectors: a preliminary investigation for the development of an immunization schedule in a guinea pig model

    Article • Infectious Diseases of Poverty, February 2021, Springer Science + Business Media

    Professor Kaissar Tabynov

  9. Development of Human Vectored Brucellosis Vaccine Formulation: Assessment of Safety and Protectiveness of Influenza Viral Vectors Expressing Brucella Immunodominant Proteins in Mice and Guinea Pigs

    Article • BioMed Research International, November 2020, Hindawi Publishing Corporation

    Professor Kaissar Tabynov

  10. Pulmonary inflammatory response to influenza virus infection in pigs is regulated by DAP12 and macrophage M1 and M2 phenotypes

    Article • Cellular Immunology, June 2020, Elsevier

    Professor Kaissar Tabynov

  11. Evaluation of Duration of Immunogenicity and Protective Efficacy of Improved Influenza Viral Vector–Based Brucella abortus Vaccine Against Brucella melitensis Infection in Sheep and Goats

    Article • Frontiers in Veterinary Science, February 2020, Frontiers

    Professor Kaissar Tabynov

  12. Corrigendum to ‘Beta-propiolactone inactivated bivalent bluetongue virus vaccine containing montanide ISA-71VG adjuvant induces long-term immune response in sheep against serotypes 4 and 16 even after 3 years of controlled vaccine storage’ [Vet. Microb...

    Article • Veterinary Microbiology, March 2019, Elsevier

    Professor Kaissar Tabynov

  13. Analysis of the efficacy of an adjuvant-based inactivated pandemic H5N1 influenza virus vaccine

    Article • Archives of Virology, February 2019, Springer Science + Business Media

    Professor Kaissar Tabynov

  14. Beta-propiolactone inactivated bivalent bluetongue virus vaccine containing Montanide ISA-71VG adjuvant induces long-term immune response in sheep against serotypes 4 and 16 even after 3 years of controlled vaccine storage

    Article • Veterinary Microbiology, November 2018, Elsevier

    Professor Kaissar Tabynov

  15. Genetic diversity of avian avulavirus 1 (Newcastle disease virus genotypes VIg and VIIb) circulating in wild birds in Kazakhstan

    Article • Archives of Virology, March 2018, Springer Science + Business Media

    Professor Kaissar Tabynov

  16. Comparison of Different Methods of Purification and Concentration in Production of Influenza Vaccine

    Article • Bulletin of Experimental Biology and Medicine, November 2017, Springer Science + Business Media

    Professor Kaissar Tabynov

  17. Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats

    Article • PLoS ONE, October 2017, PLOS

    Professor Kaissar Tabynov

  18. First evaluation of an influenza viral vector based Brucella abortus vaccine in sheep and goats: Assessment of safety, immunogenicity and protective efficacy against Brucella melitensis infection

    Article • Veterinary Microbiology, December 2016, Elsevier

    Professor Kaissar Tabynov

  19. Simultaneous subcutaneous and conjunctival administration of the influenza viral vector based Brucella abortus vaccine to pregnant heifers provides better protection against B. abortus 544 infection than the commercial B. abortus S19 vaccine

    Article • Vaccine, September 2016, Elsevier

    Professor Kaissar Tabynov

  20. Inactivated porcine reproductive and respiratory syndrome virus vaccine adjuvanted with Montanide™ Gel 01 ST elicits virus-specific cross-protective inter-genotypic response in piglets

    Article • Veterinary Microbiology, August 2016, Elsevier

    Professor Kaissar Tabynov

  21. Influenza viral vector basedBrucella abortusvaccine: a novel vaccine candidate for veterinary practice

    Article • Expert Review of Vaccines, July 2016, Taylor & Francis

    Professor Kaissar Tabynov

  22. Technological aspects of manufacturing the first Kazakhstan seasonal influenza split vaccine

    Article • Biotechnology Theory and practice, June 2016, National Center for Biotechnology

    Professor Kaissar Tabynov

  23. Commission trials of the manufacturing technology, and physical and immunobiological properties, of a novel live modified cold-adapted viral vaccine against equine influenza

    Article • Biotechnology Theory and practice, January 2016, National Center for Biotechnology

    Professor Kaissar Tabynov

  24. Safety of the novel influenza viral vector Brucella abortus vaccine in pregnant heifers

    Article • January 2016, FapUNIFESP (SciELO)

    Professor Kaissar Tabynov

  25. Prime-booster vaccination of cattle with an influenza viral vector Brucella abortus vaccine induces a long-term protective immune response against Brucella abortus infection

    Article • Vaccine, January 2016, Elsevier

    Professor Kaissar Tabynov

  26. An influenza viral vector Brucella abortus vaccine induces good cross-protection against Brucella melitensis infection in pregnant heifers

    Article • Vaccine, July 2015, Elsevier

    Professor Kaissar Tabynov

  27. Erratum

    Article • Australian Veterinary Journal, February 2015, Wiley

    Professor Kaissar Tabynov

  28. Safety and immunogenicity of a novel cold-adapted modified-live equine influenza virus vaccine

    Article • Australian Veterinary Journal, October 2014, Wiley

    Professor Kaissar Tabynov

  29. Novel vector vaccine against Brucella abortus based on influenza A viruses expressing Brucella L7/L12 or Omp16 proteins: Evaluation of protection in pregnant heifers

    Article • Vaccine, October 2014, Elsevier

    Professor Kaissar Tabynov

  30. Duration of the protective immune response after prime and booster vaccination of yearlings with a live modified cold-adapted viral vaccine against equine influenza

    Article • Vaccine, May 2014, Elsevier

    Professor Kaissar Tabynov

  31. Safety of the novel vector vaccine against Brucella abortus based on recombinant influenza viruses expressing Brucella L7/L12 and OMP16 proteins, in cattle

    Article • April 2014, Peertechz.com

    Professor Kaissar Tabynov

  32. Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infection

    Article • Virology Journal, April 2014, Springer Science + Business Media

    Professor Kaissar Tabynov

  33. Novel influenza virus vectors expressing Brucella L7/L12 or Omp16 proteins in cattle induced a strong T-cell immune response, as well as high protectiveness against B. abortus infection

    Article • Vaccine, April 2014, Elsevier

    Professor Kaissar Tabynov

  34. Preliminary Assessment of Safety and Immunogenicity of an Inactivated Whole-Virion Vaccine against Influenza А (H1N1) Pdm09 Containing Aluminum Hydroxide Adjuvant: A Randomized, Blinded Phase I Clinical Study

    Article • Journal of Vaccines & Vaccination, January 2013, OMICS Publishing Group

    Professor Kaissar Tabynov

  35. Immunogenic and protective properties of the first kazakhstan vaccine against pandemic influenza A (H1N1) pdm09 in Ferrets

    Article • Virologica Sinica, November 2012, Elsevier

    Professor Kaissar Tabynov

  36. Immunogenicity of the inactivated oil emulsion influenza A (H5N1) vaccine in chickens

    Article • Agriculture and Biology Journal of North America, May 2010, Science Hub

    Professor Kaissar Tabynov